XTX Topco’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-35,331
Closed -$1.3M 3303
2025
Q2
$1.3M Buy
35,331
+20,187
+133% +$697K 0.05% 519
2025
Q1
$595K Sell
15,144
-20,302
-57% -$914K 0.03% 901
2024
Q4
$1.65M Buy
35,446
+19,928
+128% +$901K 0.14% 125
2024
Q3
$701K Buy
15,518
+4,169
+37% +$198K 0.05% 598
2024
Q2
$559K Buy
11,349
+3,851
+51% +$157K 0.05% 603
2024
Q1
$257K Buy
7,498
+828
+12% +$29.9K 0.03% 975
2023
Q4
$246K Sell
6,670
-20,036
-75% -$463K 0.05% 793
2023
Q3
$541K Sell
26,706
-2,916
-10% -$64.1K 0.09% 353
2023
Q2
$606K Buy
+29,622
New +$444K 0.11% 262

Other funds holding TWST

XTX Topco's TWST Position: Q3 2025 in Review

XTX Topco sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 35,331 shares — an estimated $1.3M sold.

XTX Topco first reported a position in TWST in Q2 2023 and held it in 9 quarters. The position peaked at $1.65M in Q4 2024. 238 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

  • XTX Topco reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
  • XTX Topco sold 35,331 Twist Bioscience shares in Q3 2025, an estimated $1.3M.
  • XTX Topco first reported a position in Twist Bioscience in Q2 2023 and held it in 9 quarters.
  • XTX Topco's Twist Bioscience position peaked at $1.65M in Q4 2024.
  • 238 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.